Illumina, Inc Illumina (NASDAQ: ILMN) Introduce Groundbreaking Genomic Profiling Test for Cancer in Europe Illumina, Inc. (NASDAQ: ILMN) has introduced TruSight Oncology (TSO) Comprehensive (EU). It's a single test that evaluates several tumor genes and biomarkers to show a patient's cancer's distinct molecular profile.
